| 1. |
Gryfe R, Swallow C, Bapat B, et al. Molecular biology for colorectal cancer〔Ｊ〕. Curr Probl Cancer, 1997; 21(5)∶233.
|
| 2. |
Stamos MJ. What′s new in colon and rectal surgery〔Ｊ〕. Am J Surg, 1998; 186(2)∶134.
|
| 3. |
Gryfe R, Di Nicola N, Lal G, et al. Inherited colorectal polyposis and cancer risk of the APC I 1 307k polymorphism〔Ｊ〕. Am J Hum Genet, 1999; 64(2)∶378.
|
| 4. |
Saito M, Yamaguchi A, Goi T, et al. Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis 〔Ｊ〕. Oncology, 1999; 56(2)∶134.
|
| 5. |
Takanishi DMJr, Angyriman L, Yaremko ML, et al. Chromosome 17p allelic loss in colorectal carcinoma〔Ｊ〕. Arch Surg, 1995; 130(6)∶585.
|
| 6. |
Lane DP. On the expression of p53 protein in human cancer〔Ｊ〕. Mol Biol Rep, 1994; 19(2)∶23.
|
| 7. |
王汉涛. p53引起的细胞凋亡和恶性肿瘤的基因治疗〔Ｊ〕. 国外医学外科学分册， 1998； 25(1)∶4.
|
| 8. |
Cheah PY, Cao X, Eu KW, et al. nm23H1 immunostaining is inversely associated with tumor staging but not overall survival or disease recurrence in colorectal carcinomas〔Ｊ〕. Br J Cancer, 1998; 77(7)∶1164.
|
| 9. |
Tabuchi Y, Nakamura T, Kuniyasu T, et al. Expressioin of nm23H1 in colorectal cancer: no association with metastasis, histological stage, or survival〔Ｊ〕. Surg Today, 1999; 29(2)∶116.
|
| 10. |
Preire H, Silva S, Juleao R, et al. Prognostic markers for colorectal cancer〔Ｊ〕. World J Surg, 1997; 21(2)∶210.
|
| 11. |
Strum I, Churn CH, Wolf G, et al. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastasis〔Ｊ〕. J Clin Oncol, 1999; 17(5)∶1364.
|
| 12. |
Menger MD, Vellnar B. Adhesion molecules as determinants of disease〔Ｊ〕. Br J Surg, 1996; 84(5)∶588.
|
| 13. |
Karatzas G, Karayiannakis AJ, Syrigos KN, et al. Ecadherin expression correlates with tumor differentiation in colorectal cancer〔Ｊ〕. Hepatogastroenterology, 1999; 46(25)∶232.
|
| 14. |
Takahashi Y, Tucker SL, Kitadal Y, et al. Vessel counts and expression of vascular endothelial growth factor in node negative colon cancer〔Ｊ〕. Arch Surg, 1997; 132(5)∶545.
|
| 15. |
Kennedy BP, Soravia C, Moffat J, et al. Overexpression of the nonpancreatic secretory group Ⅱ PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients〔Ｊ〕. Cancer Res, 1998; 58(3)∶500.
|
| 16. |
Kos J, Nielsen HJ, Krasovec M, et al. prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer〔Ｊ〕. Clin Cancer Res, 1998; 4(6)∶1511.
|
| 17. |
Cheng AJ, Tang R, Wang JY, et al. Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers〔Ｊ〕. J Natl Cancer Inst, 1998; 90(40)∶316.
|
1/5
WeChat